Exchange: OTC·Updated 03:58 PM EDT

BCLI Brainstorm Cell Therapeutics, Inc.

$1.00
$0.00
(0.00%)
Today
Reported EarningsAug 14
Mkt Cap$11.03M
Vol15,950.00

About BCLI

Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function. The company was founded by Irit Arbel on September 22, 2000 and is headquartered in New York, NY.
35

Bearish Sentiment

How do you feel about BCLI?

Advertisement|Remove ads.